NDA Submitted for Novel Insomnia Treatment Lemborexant
The NDA includes data from two Phase 3 clinical trials (SUNRISE 1 and SUNRISE 2) which included approximately 2000 patients.
Insomnia
Positive Results for Lemborexant in Insomnia Disorder Study
SUNRISE 2 is an ongoing long-term efficacy and safety study (N=900) of adults (aged 18 to 88 years) with insomnia disorder who have difficulty falling and/or staying asleep.
Digital Cognitive Therapy Eases Daytime Effects of Insomnia
Digital CBT is effective in improving functional health, psychological well-being, and sleep-related quality of life in people reporting insomnia.
Acute Insomnia Found to Be Common Among Good Sleepers
Acute insomnia is common among good sleepers, and about three-quarters of those with AI recover good sleep.
Insomnia Found to Be Common but Mild in Older Adults
Insomnia is common in older community-dwelling adults, but usually mild.
Antidepressant Use for Insomnia: Is It Effective?
For this study, researchers identified 23 randomized controlled trials that included a total of 2806 adults with a primary diagnosis of insomnia to examine the relationship between antidepressant use and insomnia treatment.
Blocking Blue Light May Reduce Insomnia
Wearing amber lenses for 2 hours before bedtime is associated with improved sleep, for individuals with insomnia symptoms.
Alzheimer Disease Linked to High Cumulative Doses of Zolpidem in Elderly
Zolpidem has been associated with memory loss and decline in cognitive function.
Prescription, OTC Sleep Medications Often Used in Older Adults
Over 33% of older adults have reported using medication to help them sleep.
Melatonin Effective for Children With Autism and Insomnia
The treatment was effective in patients with autism with or without comorbid ADHD or neurogenetic disorders.
Next post in Autism Spectrum Disorder
